These insights into CHI3L1’s dual role in ischemic stroke suggest that therapeutic strategies aimed at modulating its activity could help balance the inflammatory responses, offering a promising direction for improving stroke management and patient recovery. This evidence concerns the gene CHI3L1 and stroke disorder.